Immediate Impact
1 by Nobel laureates 65 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Works of Cancan Chen being referenced
A recombinant chimeric protein specifically induces mutant KRAS degradation and potently inhibits pancreatic tumor growth
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Cancan Chen | 168 | 84 | 205 | 29 | 547 | |
| Yue Wang | 27 | 12 | 97 | 55 | 619 | |
| Mengyu Zhang | 158 | 64 | 372 | 46 | 628 | |
| Guangyu Liu | 48 | 18 | 159 | 27 | 528 | |
| Xinglu Zhang | 62 | 63 | 149 | 28 | 545 | |
| Na Ta | 120 | 33 | 277 | 43 | 570 | |
| Chao Hu | 80 | 16 | 233 | 51 | 570 | |
| František Hubatka | 34 | 20 | 147 | 24 | 545 | |
| Ping Li | 14 | 28 | 103 | 17 | 505 | |
| Shu Liu | 10 | 8 | 35 | 54 | 487 | |
| Xiaoqiang Hou | 55 | 9 | 161 | 28 | 533 |
All Works
Login with ORCID to disown or claim papers
Loading papers...